miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression
25
This study was funded by the National Natural Science Foundation of China 31225016,81170418 and 81125016,the Ministry of Science and Technology of China 2014CB910601,2011ZX09307-302-01,2011CB966304 and 2011CB910204,the Science and Technology Commission of Shanghai Municipality 12JC1409500 and 14XD1404200,and the Natural Science Foundation of Jiangsu Province BK20131084.
2015-05-19(万方平台首次上网日期,不代表论文的发表时间)
477-495